Wanggang Zhang

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Wanhong Zhao, Jie Liu, Baiyan Wang et al. · Journal of Hematology & Oncology · 2018 · 526 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +19

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Wanhong Zhao, Baiyan Wang, Lijuan Chen et al. · Journal of Hematology & Oncology · 2022 · 139 citations · Full text

Involvement of Oxidative Stress in the Relapse of Acute Myeloid Leukemia

Fuling Zhou, Wanggang Zhang, Yongchang Wei et al. · Journal of Biological Chemistry · 2010 · 120 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Acute Myeloid Leukemia +11

Clinical significance of B7-H1（PD-L1）expression in human acute leukemia

Xiangli Chen, Shuhu Liu, Liancai Wang et al. · Cancer Biology & Therapy · 2008 · 117 citations · Full text

Promote Tumor Growth, Mixed-phenotype Acute Leukemia, Immunology +16

Management of cytokine release syndrome related to CAR-T cell therapy

Hongli Chen, Fangxia Wang, Pengyu Zhang et al. · Frontiers of Medicine · 2019 · 106 citations

Inflammation, Autoimmune Disease, T-regulatory Cell +7